InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by McKhann Chas, 董事长兼首席执行官. Director active across 3 companies, notably Apollo Endosurgery, Inc.. Cumulatively, 8 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €297k. History available since 18 August 2021. The latest transaction was disclosed on 1 March 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to McKhann Chas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
722,396 股Common StockSEC:0001140361-24-041406:0
110,313 股0Common StockSEC:0001593968-24-000432:0
612,083 股0Common StockSEC:0001593968-23-001398:0
689,880 股Common StockSEC:0001251769-23-000027:0
112,607 股0Common StockSEC:0001251769-22-000053:0
66,553 股@ US$5.4269.8% 占其流量Common StockSEC:0001251769-22-000036:0
21,156 股@ US$8.2115.9% 占其流量Common StockSEC:0001251769-21-000107:0
21,156 股@ US$8.2130.2% 占其流量Common StockSEC:0001251769-21-000105:0
8 条申报中的 8 条
About McKhann Chas
McKhann Chas is President and CEO and has filed 8 forms in total. Across the 8 most recent filings, reported sales total EUR 296824, covering the period from 2021-08-20 to 2024-09-18, and the modal transaction nature is Attribution. The filings concern Apollo Endosurgery, Inc. and Silk Road Medical Inc.
